| Předmět: |
|
| Zdroj: |
Cancer Weekly; 11/9/2023, p620-620, 1p |
| Abstrakt: |
Keywords: Beijing; People's Republic of China; Asia; Alkylating Agents; Anthraquinones; Antibiotics; Antigens; Antineoplastics; Antiparasitics; Biological Factors; CD Antigens; Cancer; Cell Adhesion Molecules; Cell Research; Chlorine Compounds; Cisplatin Therapy; Drug Delivery; Drug Delivery Systems; Drugs and Therapies; Emerging Technologies; Fucoidan Therapy; Glycoproteins; Health and Medicine; Immunology; Lectins; Membrane Glycoproteins; Membrane Proteins; Mitoxantrone; Mitoxantrone Therapy; Nanogels; Nanotechnology; Nitrogen Compounds; Oncology; P-Selectin; Pharmaceuticals; Platelet Membrane Glycoproteins; Platinum Compounds; Proteins; Radiotherapy; Selectins EN Beijing People's Republic of China Asia Alkylating Agents Anthraquinones Antibiotics Antigens Antineoplastics Antiparasitics Biological Factors CD Antigens Cancer Cell Adhesion Molecules Cell Research Chlorine Compounds Cisplatin Therapy Drug Delivery Drug Delivery Systems Drugs and Therapies Emerging Technologies Fucoidan Therapy Glycoproteins Health and Medicine Immunology Lectins Membrane Glycoproteins Membrane Proteins Mitoxantrone Mitoxantrone Therapy Nanogels Nanotechnology Nitrogen Compounds Oncology P-Selectin Pharmaceuticals Platelet Membrane Glycoproteins Platinum Compounds Proteins Radiotherapy Selectins 620 620 1 11/06/23 20231107 NES 231107 2023 NOV 7 (NewsRx) -- By a News Reporter-Staff News Editor at Cancer Weekly -- A new study on Cancer is now available. The news correspondents obtained a quote from the research from Peking Union Medical College Hospital, "Tumoral P-selectin can be rapidly upregulated after ionization radiation, indicating it is a highly selective target for drug delivery. [Extracted from the article] |
| Databáze: |
Complementary Index |
| Externí odkaz: |
|
